0001415889-19-001255.txt : 20191104 0001415889-19-001255.hdr.sgml : 20191104 20191104160519 ACCESSION NUMBER: 0001415889-19-001255 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191031 FILED AS OF DATE: 20191104 DATE AS OF CHANGE: 20191104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AHMED NADIM CENTRAL INDEX KEY: 0001731193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 191189761 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-11042019_041106.xml X0306 4 2019-10-31 0000816284 CELGENE CORP /DE/ CELG 0001731193 AHMED NADIM C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 false true false false PRES., GLOBAL HEM. AND ONC. Common Stock 2019-10-31 4 M 0 3281 0 A 15915 D Common Stock 2019-10-31 4 F 0 1096 108.03 D 14819 D Common Stock 1966 I 401(k) Plan Restricted Stock Unit 2019-10-31 4 M 0 3281 0 D Common Stock 3281 0 D The restricted stock units granted to the reporting person on October 31, 2016 have vested and settled for shares of the Company's common stock. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan). /s/ Jonathan Biller, Attorney-in-Fact 2019-11-04